Review



terk  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    R&D Systems terk
    Pathway protein concentrations in autologous reference and cancer tissue.
    Terk, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/terk+dyc1230c/Human%2FMouse%2FRat+Total+ERK2+DuoSet+IC+ELISA/pmc07675974-73-12-16
    Average 90 stars, based on 3 article reviews
    terk - by Bioz Stars, 2026-09
    90/100 stars

    Images

    1) Product Images from "Decreased concentrations of intracellular signaling proteins in colon cancer patients with BRAF mutations"

    Article Title: Decreased concentrations of intracellular signaling proteins in colon cancer patients with BRAF mutations

    Journal: Scientific Reports

    doi: 10.1038/s41598-020-77109-8

    Pathway protein concentrations in autologous reference and cancer tissue.
    Figure Legend Snippet: Pathway protein concentrations in autologous reference and cancer tissue.

    Techniques Used:

    Pathway protein concentrations according to mutation status. The median and range are shown for each pathway protein. Wt is wildtype for all investigated mutations. All measurements are in pg/ml.
    Figure Legend Snippet: Pathway protein concentrations according to mutation status. The median and range are shown for each pathway protein. Wt is wildtype for all investigated mutations. All measurements are in pg/ml.

    Techniques Used: Mutagenesis

    Related Articles

    Mutagenesis:

    Article Title: Decreased concentrations of intracellular signaling proteins in colon cancer patients with BRAF mutations
    Article Snippet: The biotinylated detector antibodies and the calibrators were tAKT (DYC1775), pAKT (DYC887B), tERK (DYC1230C), pERK (DYC1018B) (R&D Systems), and cyclin d (ab218793) (abcam).



    Similar Products

    terk  (R&D Systems)
    90
    R&D Systems terk
    Pathway protein concentrations in autologous reference and cancer tissue.
    Terk, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/terk+dyc1230c/Human%2FMouse%2FRat+Total+ERK2+DuoSet+IC+ELISA/pmc07675974-73-12-16
    Average 90 stars, based on 1 article reviews
    terk - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Pathway protein concentrations in autologous reference and cancer tissue.

    Journal: Scientific Reports

    Article Title: Decreased concentrations of intracellular signaling proteins in colon cancer patients with BRAF mutations

    doi: 10.1038/s41598-020-77109-8

    Figure Lengend Snippet: Pathway protein concentrations in autologous reference and cancer tissue.

    Article Snippet: The biotinylated detector antibodies and the calibrators were tAKT (DYC1775), pAKT (DYC887B), tERK (DYC1230C), pERK (DYC1018B) (R&D Systems), and cyclin d (ab218793) (abcam).

    Techniques:

    Pathway protein concentrations according to mutation status. The median and range are shown for each pathway protein. Wt is wildtype for all investigated mutations. All measurements are in pg/ml.

    Journal: Scientific Reports

    Article Title: Decreased concentrations of intracellular signaling proteins in colon cancer patients with BRAF mutations

    doi: 10.1038/s41598-020-77109-8

    Figure Lengend Snippet: Pathway protein concentrations according to mutation status. The median and range are shown for each pathway protein. Wt is wildtype for all investigated mutations. All measurements are in pg/ml.

    Article Snippet: The biotinylated detector antibodies and the calibrators were tAKT (DYC1775), pAKT (DYC887B), tERK (DYC1230C), pERK (DYC1018B) (R&D Systems), and cyclin d (ab218793) (abcam).

    Techniques: Mutagenesis